You are here

Omontys

Affymax and Takeda Announce Termination of Omontys (peginesatide) Product Collaboration and License Agreement

Pipeline Review

Sat, 06/14/14 - 09:51 am

New Data Show Omontys At Least 4x Worse Than Reported: Now 22 Suspected Deaths

Seeking Alpha

Tue, 10/15/13 - 11:54 am

Takeda Withdraws MAA for Omontys in Europe

NASDAQ

Sat, 07/6/13 - 12:30 pm

chronic kidney disease

FDA saw early reports of severe Omontys reactions: WSJ

Fierce Pharma

Mon, 04/1/13 - 11:20 am

Amgen Benefits From Affymax Recall

Seeking Alpha

Tue, 03/5/13 - 11:58 am

Blood Drug Woes Could Weigh on FDA and its Approval of New, Copycat Biologic Medicines

Forbes

Mon, 02/25/13 - 10:13 am

follow-on biologics

Down 85%! Why Affymax Is Getting Crushed This Morning

Motley Fool

Mon, 02/25/13 - 09:50 am

Affymax, Takeda recall anaemia drug Omontys after deaths

Reuters

Sun, 02/24/13 - 02:21 pm

Affymax Rises On Deal With Fresenius For Kidney Therapy

Bloomberg

Fri, 07/13/12 - 12:25 pm

Affymax gets Medicare payment code for Omontys

Yahoo/AP

Fri, 04/13/12 - 10:47 am

Affymax Poised To Take On Amgen?

Seeking Alpha

Fri, 04/6/12 - 11:15 am

chronic kidney disease

Affymax's Anemia Drug Will Create Added Competition For Amgen

Seeking Alpha

Sun, 04/1/12 - 12:12 pm

FDA OKs New Anemia Med That Challenges Amgen

Pharmalot

Wed, 03/28/12 - 11:27 am